About Evolva
Located at Duggingerstrasse 23 in Basel-Landschaft, Evolva’s cosmetic lab operates under strict corporate governance standards. Following its recent acquisition by Danstar Ferment AG, the company maintains:
- SIX Swiss Exchange listing (ISIN CH0021218067)
- Regular financial reporting and disclosure requirements
- Transparent shareholder communications
- Compliance with Swiss regulatory frameworks
The facility serves Switzerland’s growing biotech sector from its strategic position in the Reinach innovation district.
Frequently asked questions
Evolva underwent these corporate changes:
- Ownership
- Acquired by Danstar Ferment AG on December 28, 2023
- Danstar Ferment AG operates as a Lallemand Inc. subsidiary
- Stock Exchange Presence
- Listed as Evolva Holding SA
- Trading on SIX Swiss Exchange
- ISIN: CH0021218067
The company maintains standard reporting and disclosure practices under Swiss financial regulations.
Recent changes in Evolva’s shareholder structure include:
- Previous Structure
- Nice & Green SA held 19.344% ownership
- Multiple institutional investors
- Public float on SIX Swiss Exchange
- Current Changes
- Nice & Green SA divested all shares
- Transfer to undisclosed third party
- New ownership disclosure pending
These changes reflect the company’s transition under Danstar Ferment AG ownership.
Evolva operates under these regulatory frameworks:
| Category | Requirements |
|---|---|
| Financial Reporting |
|
| Regulatory Disclosure |
|
More details about Evolva
About Evolva: A Swiss leader in biotechnology
Located at Duggingerstrasse 23 in Kanton Reinach, Basel-Landschaft, Evolva operates as a cosmetic lab and biotechnology company in Switzerland. The firm has established itself in the heart of Switzerland’s biotechnology hub.
Services and expertise
From its strategic location in Basel-Landschaft, Evolva provides specialized laboratory services, focusing on fermentation technologies and innovative solutions for the cosmetic and biotechnology sectors.
Corporate structure and market presence
Operating under Evolva Holding SA, the company maintains its listing on the SIX Swiss Exchange with ISIN CH0021218067. In December 2023, the company underwent a significant transformation through its acquisition by Danstar Ferment AG, a subsidiary of Lallemand Inc.
Recent developments
A notable change in ownership structure occurred when Nice & Green SA, which previously held a 19.344% stake, divested its entire shareholding. This transaction reflects the dynamic nature of the Swiss biotechnology sector.
Financial transparency and reporting
In line with Swiss market regulations, Evolva maintains regular financial reporting schedules. The company will release its IFRS financial statements for 2023 and the first half of 2024 by October 31, 2024.
Location advantages
The company’s presence in Basel-Landschaft positions it within Switzerland’s renowned life sciences cluster. This location provides access to specialized talent and research facilities, supporting its operations as a leading biotechnology firm.
Company gallery
